| Authors: |
Deutsch JS; Departments of Dermatology, Pathology, and Oncology, The Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, USA., Cottrell TR; Queen's University Sinclair Cancer Research Institute, Kingston, Canada., Chen KY; Department of Dermatology, Johns Hopkins University SOM, Baltimore, USA., De Andrea CE; Department of Pathology, University of Navarra, Pamplona, Spain., Baraban E; Department of Pathology, Johns Hopkins University SOM, Baltimore, USA., Fiset PO; Department of Pathology, McGill University Health Centre, Montréal, Canada., Jedrych JJ; Department of Dermatology, Johns Hopkins University SOM, Baltimore, USA., Orr CE; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Real FX; Epithelial Carcinogenesis Group, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Centre, Melbourne, Australia., Schürch CM; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Seethala R; University of Pittsburgh Medical Center, Department of Pathology, Pittsburgh, USA., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, USA., Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, USA., Tetzlaff M; Departments of Pathology and Dermatology, Dermatopathology and Oral Pathology Unit, University of California San Francisco, San Francisco, USA., Wang H; Division of Quantitative Sciences, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA., Wang T; Division of Quantitative Sciences, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA., Weissferdt A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Xu X; Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA., Ziai J; Genentech, Inc., San Francisco, USA., Cimino-Mathews A; Department of Pathology, Johns Hopkins University SOM, Baltimore, USA., Taube JM; Departments of Dermatology, Pathology, and Oncology, The Mark Foundation Center for Advanced Imaging and Genomics and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University SOM, Baltimore, USA. Electronic address: jtaube1@jhmi.edu. |
